{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:12:35Z","timestamp":1788581555729,"version":"build-2803163510"},"reference-count":15,"publisher":"Japanese Society of Internal Medicine","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,9,1]]},"DOI":"10.2169\/internalmedicine.6642-25","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T22:08:09Z","timestamp":1769897289000},"page":"2407-2411","source":"Crossref","is-referenced-by-count":0,"title":["Macrophage Activation Syndrome Associated with Adult-onset Still's Disease Successfully Treated with Plasma Exchange and Canakinumab"],"prefix":"10.2169","volume":"65","author":[{"given":"Wataru","family":"Kiyohara","sequence":"first","affiliation":[{"name":"Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muneyuki","family":"Hatta","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine, Japan"},{"name":"Department of Rheumatology, Osaka Saiseikai Nakatsu Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Nakazawa","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Osaka Saiseikai Nakatsu Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunichi","family":"Kinoshita","sequence":"additional","affiliation":[{"name":"Department of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Kakutani","sequence":"additional","affiliation":[{"name":"Department of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenya","family":"Sugimoto","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukina","family":"Yokoyama","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuhei","family":"Ishihara","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Katsushima","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Fukumoto","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryu","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Emoto","sequence":"additional","affiliation":[{"name":"Department of Metabolism, Endocrinology and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motomu","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Osaka Metropolitan University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Bagnari V, Colina M, Ciancio G, Govoni M, Trotta F. Adult-onset Still's disease. Rheumatol Int 30: 855-862, 2010.","DOI":"10.1007\/s00296-009-1291-y"},{"key":"2","unstructured":"2. Yang XP, Wang M, Li TF, Li W, Zhang L, Liu SY. Predictive factors and prognosis of macrophage activation syndrome associated with adult-onset Still's disease. Clin Exp Rheumatol 37 (Suppl 121): 83-88, 2019."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Adachi S, Takase-Minegishi K, Maeda A, et al. Risk of macrophage activation syndrome in patients with adult-onset Still's disease treated with IL-1 and IL-6 inhibitors: a meta-analysis and single-center experience. Rheumatol Ther 10: 1623-1636, 2023.","DOI":"10.1007\/s40744-023-00600-x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Chaisrimaneepan N, Yingchoncharoen P, Pangkanon W, Kanitthamniyom C. Macrophage activation syndrome-associated adult onset Still disease treatment: a scoping review of case reports and case series. Proc (Bayl Univ Med Cent) 38: 499-511, 2025.","DOI":"10.1080\/08998280.2025.2482315"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Chen Y, Hu Z, Cai S, Shen G, Zhong J, Dong L. Efficacy of plasma exchange on top of standard immunosuppressive therapy in adult autoimmune inflammatory rheumatic diseases-associated macrophage activation syndrome, a single center real-world analysis. Semin Arthritis Rheum 55: 152043, 2022.","DOI":"10.1016\/j.semarthrit.2022.152043"},{"key":"6","unstructured":"6. Yamaguchi M, Ohta A, Tsunematsu T, et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol 19: 424-430, 1992."},{"key":"7","unstructured":"7. Ravelli A, Minoia F, Davi S, et al. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Ann Rheum Dis 75: 481-489, 2016."},{"key":"8","unstructured":"8. Fautrel B, Mitrovic S, De Matteis A, et al. EULAR\/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's disease. Ann Rheum Dis 83: 1614-1627, 2024."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ruscitti P, Cantarini L, Nigrovic PA, McGonagle D, Giacomelli R. Recent advances and evolving concepts in Still's disease. Nat Rev Rheumatol 20: 116-132, 2024.","DOI":"10.1038\/s41584-023-01065-6"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Gao Q, Yuan Y, Wang Y, et al. Clinical characteristics of macrophage activation syndrome in adult-onset Still's disease. Clin Exp Rheumatol 39 (Suppl 132): 59-66, 2021.","DOI":"10.55563\/clinexprheumatol\/lp2u7g"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Tsuboi H, Segawa S, Yagishita M, et al. Activation mechanisms of monocytes\/macrophages in adult-onset Still disease. Front Immunol 13: 953730, 2022.","DOI":"10.3389\/fimmu.2022.953730"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kim JW, Ahn MH, Jung JY, Suh CH, Kim HA. An update on the pathogenic role of neutrophils in systemic juvenile idiopathic arthritis and adult-onset Still's disease. Int J Mol Sci 22: 13038, 2021.","DOI":"10.3390\/ijms222313038"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Iwata N, Nishimura K, Hara R, et al. Long-term efficacy and safety of canakinumab in the treatment of systemic juvenile idiopathic arthritis in Japanese patients: results from an open-label Phase III study. Mod rheumatol 33: 1162-1170, 2023.","DOI":"10.1093\/mr\/roac128"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kedor C, Listing J, Zernicke J, et al. Canakinumab for treatment of adult-onset Still's disease to achieve reduction of arthritic manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial. Ann Rheum Dis 79: 1090-1097, 2020.","DOI":"10.1136\/annrheumdis-2020-217155"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Vitale A, Caggiano V, Sfikakis PP, et al. Efficacy of canakinumab in patients with Still's disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still's Disease. Front Med (Lausanne) 10: 1256243, 2023.","DOI":"10.3389\/fmed.2023.1256243"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/17\/65_6642-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T03:31:16Z","timestamp":1788579076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/17\/65_6642-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":15,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6642-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"article-number":"6642-25"}}